New Haven, CT, United States of America

Xiaodong Jiang

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Yale University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaodong Jiang. Retrieved from https://idiyas.com/inventor/xiaodong-jiang-4dpesx4r

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Xiaodong Jiang

Introduction

Xiaodong Jiang is a prominent inventor based in New Haven, CT (US). He has made significant contributions to the field of biomedical research, particularly in the area of immune response.

Latest Patents

Xiaodong Jiang holds a patent titled "RIG-I Agonists and Treatments Using Same." This patent reflects his innovative approach to developing treatments that enhance the immune system's ability to fight infections.

Career Highlights

Currently, Xiaodong Jiang is affiliated with Yale University, where he conducts research and contributes to advancements in immunology. His work has garnered attention for its potential impact on therapeutic strategies.

Collaborations

Xiaodong has collaborated with notable researchers, including Anna Marie Pyle and Akiko Iwasaki. These partnerships have enriched his research and expanded the scope of his innovations.

Conclusion

Xiaodong Jiang's contributions to the field of immunology through his patent and research at Yale University highlight his role as an influential inventor. His work continues to pave the way for new treatments and advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…